Comparison of efficacy and tolerability of different brands of amlodipine in patients with mild to moderate hypertension

Background: The efficacy of amlodipine, a calcium channel blocker, in treating systemic hypertension is well established but the most efficacious brand of this drug is still uncertain. The cost of different brands of amlodipine is tremendously different which may affect decision-making in hypertens...

Full description

Bibliographic Details
Main Authors: Molouk Hadjibabaie, SeyedHamid Khoee, Ebrahim Nematipoor, Kheirollah Gholami, Afsaneh Fatahian, Zahra Jahangard
Format: Article
Language:English
Published: Research Center for Rational Use of Drugs (RCRUD) 2015-10-01
Series:Journal of Pharmaceutical Care
Subjects:
Online Access:https://jpc.tums.ac.ir/index.php/jpc/article/view/10
id doaj-324476c95a3d4252b299d178832c157d
record_format Article
spelling doaj-324476c95a3d4252b299d178832c157d2020-11-25T03:27:53ZengResearch Center for Rational Use of Drugs (RCRUD)Journal of Pharmaceutical Care2322-46302322-45092015-10-011210Comparison of efficacy and tolerability of different brands of amlodipine in patients with mild to moderate hypertensionMolouk Hadjibabaie0SeyedHamid Khoee1Ebrahim Nematipoor2Kheirollah Gholami3Afsaneh Fatahian4Zahra Jahangard5Department of Clinical Pharmacy, and Research Center for Rational Use of Drugs, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, IranDepartment of Clinical Pharmacy, and Research Center for Rational Use of Drugs, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, IranDepartment of Cardiology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, IranDepartment of Clinical Pharmacy, and Research Center for Rational Use of Drugs, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, IranDepartment of Clinical Pharmacy, and Research Center for Rational Use of Drugs, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, IranDepartment of Clinical Pharmacy, and Research Center for Rational Use of Drugs, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran Background: The efficacy of amlodipine, a calcium channel blocker, in treating systemic hypertension is well established but the most efficacious brand of this drug is still uncertain. The cost of different brands of amlodipine is tremendously different which may affect decision-making in hypertension treatment. The purpose of this study was to compare the efficacy and safety of different brands of amlodipine (Amlodipine, Amlopress, and Norvasc) in the treatment of hypertension in adult patients. Methods: This was a double-blind, randomized, three-sequence crossover study. Ambulatory patients with hypertension who had the inclusion criteria were enrolled. Patients were randomized and entered into three groups to receive either brand of amlodipine in a crossover method. After every four weeks of treatment completed, the other brand of drug was prescribed. The total period of the study was 12 weeks for all three drugs including four weeks for each brand. Results: A total of 20 patients entered to the study, 15 completed the 12-week treatment schedule. The absolute reductions in seated and supine systolic blood pressure (SBP) and diastolic blood pressure (DBP) were similar with all three brands during the 4 weeks of treatment. Headache, malaise and weakness were the most common reported adverse effects (AE) with all three drugs. Generic amlodipine had the most AE as compared with other brands. These AE were mild and did not require withdrawal of the drug. Conclusion: There is no statistical difference in lowering blood pressure by three different brands of amlodipine thus everyone which has the lowest price can be the first choice. https://jpc.tums.ac.ir/index.php/jpc/article/view/10AmlodipineAmlopressNorvascHypertension
collection DOAJ
language English
format Article
sources DOAJ
author Molouk Hadjibabaie
SeyedHamid Khoee
Ebrahim Nematipoor
Kheirollah Gholami
Afsaneh Fatahian
Zahra Jahangard
spellingShingle Molouk Hadjibabaie
SeyedHamid Khoee
Ebrahim Nematipoor
Kheirollah Gholami
Afsaneh Fatahian
Zahra Jahangard
Comparison of efficacy and tolerability of different brands of amlodipine in patients with mild to moderate hypertension
Journal of Pharmaceutical Care
Amlodipine
Amlopress
Norvasc
Hypertension
author_facet Molouk Hadjibabaie
SeyedHamid Khoee
Ebrahim Nematipoor
Kheirollah Gholami
Afsaneh Fatahian
Zahra Jahangard
author_sort Molouk Hadjibabaie
title Comparison of efficacy and tolerability of different brands of amlodipine in patients with mild to moderate hypertension
title_short Comparison of efficacy and tolerability of different brands of amlodipine in patients with mild to moderate hypertension
title_full Comparison of efficacy and tolerability of different brands of amlodipine in patients with mild to moderate hypertension
title_fullStr Comparison of efficacy and tolerability of different brands of amlodipine in patients with mild to moderate hypertension
title_full_unstemmed Comparison of efficacy and tolerability of different brands of amlodipine in patients with mild to moderate hypertension
title_sort comparison of efficacy and tolerability of different brands of amlodipine in patients with mild to moderate hypertension
publisher Research Center for Rational Use of Drugs (RCRUD)
series Journal of Pharmaceutical Care
issn 2322-4630
2322-4509
publishDate 2015-10-01
description Background: The efficacy of amlodipine, a calcium channel blocker, in treating systemic hypertension is well established but the most efficacious brand of this drug is still uncertain. The cost of different brands of amlodipine is tremendously different which may affect decision-making in hypertension treatment. The purpose of this study was to compare the efficacy and safety of different brands of amlodipine (Amlodipine, Amlopress, and Norvasc) in the treatment of hypertension in adult patients. Methods: This was a double-blind, randomized, three-sequence crossover study. Ambulatory patients with hypertension who had the inclusion criteria were enrolled. Patients were randomized and entered into three groups to receive either brand of amlodipine in a crossover method. After every four weeks of treatment completed, the other brand of drug was prescribed. The total period of the study was 12 weeks for all three drugs including four weeks for each brand. Results: A total of 20 patients entered to the study, 15 completed the 12-week treatment schedule. The absolute reductions in seated and supine systolic blood pressure (SBP) and diastolic blood pressure (DBP) were similar with all three brands during the 4 weeks of treatment. Headache, malaise and weakness were the most common reported adverse effects (AE) with all three drugs. Generic amlodipine had the most AE as compared with other brands. These AE were mild and did not require withdrawal of the drug. Conclusion: There is no statistical difference in lowering blood pressure by three different brands of amlodipine thus everyone which has the lowest price can be the first choice.
topic Amlodipine
Amlopress
Norvasc
Hypertension
url https://jpc.tums.ac.ir/index.php/jpc/article/view/10
work_keys_str_mv AT moloukhadjibabaie comparisonofefficacyandtolerabilityofdifferentbrandsofamlodipineinpatientswithmildtomoderatehypertension
AT seyedhamidkhoee comparisonofefficacyandtolerabilityofdifferentbrandsofamlodipineinpatientswithmildtomoderatehypertension
AT ebrahimnematipoor comparisonofefficacyandtolerabilityofdifferentbrandsofamlodipineinpatientswithmildtomoderatehypertension
AT kheirollahgholami comparisonofefficacyandtolerabilityofdifferentbrandsofamlodipineinpatientswithmildtomoderatehypertension
AT afsanehfatahian comparisonofefficacyandtolerabilityofdifferentbrandsofamlodipineinpatientswithmildtomoderatehypertension
AT zahrajahangard comparisonofefficacyandtolerabilityofdifferentbrandsofamlodipineinpatientswithmildtomoderatehypertension
_version_ 1724586632054571008